08 May 2018
Squeezing generic players on pricing could result in increased medicine shortages
By Staff Writer
While big pharmaceutical companies continue to stress the need to pay for innovation amid calls for the cost of originator products to be lowered, the generic industry is starting to find its own voice against increasing demands to drop prices that are already low.
